Epirubicin (Ellence)

An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Also Known As:
Ellence; 4'-Epi-Adriamycin; 4'-Epi-DXR; 4'-Epi-Doxorubicin; EPI-cell; Epilem; Epirubicin Hydrochloride; Farmorubicin; Farmorubicina; Farmorubicine; IMI-28; Kenfarma Brand of Epirubicin Hydrochloride; Lemery Brand of Epirubicin Hydrochloride; NSC-256942; Pfizer Brand of Epirubicin Hydrochloride; Pharmorubicin; cell pharm Brand of Epirubicin; 4' Epi Adriamycin; 4' Epi DXR; 4' Epi Doxorubicin; 4' Epiadriamycin; 4' Epidoxorubicin; EPI cell; EPIcell; Hydrochloride, Epirubicin; IMI 28; IMI28; NSC 256942; NSC256942; 4'-Epiadriamycin; 4'-Epidoxorubicin; 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
Networked: 2778 relevant articles (340 outcomes, 1059 trials/studies)

Relationship Network

Drug Context: Research Results